Furthermore, it has been reported that the loss of ACADL enhanced tumor growth by inhibiting the expression of the suppressor gene phosphatase and tensin homolog deleted on chromosome ten PTEN) in vivo; therefore, the loss of ACADL is correlated with poor clinical prognosis of HCC patients (69). The gene discussed is ACADL; the disease is hepatocellular carcinoma.